STAT5 has previously been associated with sex differences in liver metabolism (27) and pulmonary hypertension (28), both with a proposed neuroendocrine regulation through hypothalamus-growth hormone-STAT5 axis. The gene discussed is STAT5A; the disease is pulmonary arterial hypertension.